Even though these alterations were more evident in the premalignant PDEC already harboring a Kras mutation, benign H6c7-pBp cells also acquired those malignancy-associated properties in the presence of macrophages and/or hyperglycemia, underscoring the relevance of early prevention options. Here, KRAS is linked to Hyperglycemia.